Welcome to IBL-America,
Your Primary Resource for:

• Diagnostic Assays

• Research Reagents

• Antibodies

• Peptides

• Proteins

What's New at IBL....

HE4 EIA Kit
A new biomarker for ovarian cancer

IBL-America, in conjunction with our partner, Fujirebio Diagnostics, Inc., now offers HE4 ELISA kits. The immunoassay test kit has been cleared by the US Food and Drug Administration for use as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer.

Exceptional products, service, and years of hands-on technical experience combine to offer you the best package of products on the market today.

Please browse our site, download the protocols or spec sheets that interest you and contact us by email or phone for additional information or to place your order.

Benefits of the HE4 Assay

• The combination of HE4 + CA125 increases sensitivity over CA125 alone
• Increased sensitivity in women with early stage (I/II) disease compared with CA125
• Increased sensitivity in premenopausal women compared with CA125
• May be used alone or in combination with CA125 to monitor epithelial ovarian cancer.

For additional information/assay protocols please click here, or

Call Us Toll-Free